Both are GLP-1 medications given as a weekly injection. Both help regulate appetite, blood sugar, and support weight loss. The difference is in how many receptors they target — and that changes how powerful the effect is.
Targets one receptor — GLP-1. Slows digestion, reduces appetite signals in the brain, and helps regulate blood sugar.
Targets two receptors — GLP-1 + GIP. The added GIP pathway improves how the body processes fat and enhances insulin sensitivity on top of everything Semaglutide does.
| Sema | Tirz | |
|---|---|---|
| Receptors targeted | 1 | 2 |
| Appetite suppression | Strong | Stronger |
| Fat metabolism | Moderate | Enhanced |
| Adjustment period | Mild | Moderate |
| Weekly injection | ✓ | ✓ |
Tirzepatide isn't better because it's newer — it's more powerful because it works on two pathways instead of one. Some people do wonderfully on Semaglutide and never need to switch. The right choice depends on your body, your goals, and how you respond. There's no one-size-fits-all.